National Organization for Rare Disorders (NORD)

http://www.rarediseases.org/

It's a non-profit, voluntary health agency that exists to serve rare-disease patients and their families. NORD is committed to the identification, treatment, and cure of rare disorders through programs of education, advocacy, research, and service. Most of the money donated to NORD goes directly to programs and services.

Originator(s): NORD
Resource added in: 30/10/2002
Objective: The NORD is a unique federation of voluntary health organizations dedicated to helping people with rare \"orphan\" diseases and assisting the organizations that serve them.
Social Support, Neuroma, Acoustic, Sarcoma, Alveolar Soft Part, Astrocytoma, Neurocutaneous Syndromes, Glioblastoma, Hodgkin Disease, Leukemia, Lymphocytic, Chronic, B-Cell, Leukemia, Myelogenous, Chronic, BCR-ABL Positive, Leukemia, Hairy Cell, Meningioma, Multiple Myeloma, Paget Disease, Extramammary, Paget's Disease, Mammary, Pheochromocytoma, Retinoblastoma, Sarcoma, Ewing, Wilms Tumor, Odontogenic Tumors, Barrett Esophagus, Bowen's Disease, Castleman Disease, Carcinoma, Renal Cell, Carcinoma, Squamous Cell, Neurocutaneous Syndromes, Gardner Syndrome, Lymphomatoid Granulomatosis, Lymphoma, Non-Hodgkin, Medulloblastoma, Melanoma, Meningioma, Peutz-Jeghers Syndrome, WAGR Syndrome, Waldenstrom Macroglobulinemia, Lymphoproliferative Disorders, Zollinger-Ellison Syndrome, Carcinoma quístico adenoideo, Neoplasmas cerebrales, Carcinoma de células de los islotes, Neoplasmas de la lengua, Hiperplasia surarrenal congénita, Neoplasmas del colon, Neoplasmas de la próstata, Neoplasmas cutáneos, Sindrome cardinoide maligno, Linfoma de célula T cutáneo, Linfoma de células manto, Sindrome de nevo basocelular, Enfermedad de Hippel-Lindau
  • Share
  • Suggest tag
    [X]
    Suggestions
    Separated by comma
    [X]
    Thank you for your suggestion.
    Communication problem. Please try again later.
  • Report error
    [X]
    Reason
    New Link (Optional)
    [X]
    Thank you for your report.
    Communication problem. Please try again later.
comments powered by Disqus